N-((3S,4S)-4-(3,4-Difluorophenyl)piperidin-3-yl)-4-(1-ethyl-1H-pyrazol-5-yl)-2-fluorobenzamide Hydrochloride

ID: ALA4847466

Chembl Id: CHEMBL4847466

PubChem CID: 164614857

Max Phase: Preclinical

Molecular Formula: C23H24ClF3N4O

Molecular Weight: 428.46

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c(F)c1.Cl

Standard InChI:  InChI=1S/C23H23F3N4O.ClH/c1-2-30-22(8-10-28-30)15-3-5-17(19(25)12-15)23(31)29-21-13-27-9-7-16(21)14-4-6-18(24)20(26)11-14;/h3-6,8,10-12,16,21,27H,2,7,9,13H2,1H3,(H,29,31);1H/t16-,21+;/m0./s1

Standard InChI Key:  USOWJIGJTLUZGC-SWSMCDPZSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 428.46

Molecular Weight (Monoisotopic): 428.1824

AlogP: 3.86

#Rotatable Bonds: 5

Polar Surface Area: 58.95

Molecular Species: BASE

HBA: 4

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 13.21

CX Basic pKa: 9.20

CX LogP: 3.43

CX LogD: 1.64

Aromatic Rings: 3

Heavy Atoms: 31

QED Weighted: 0.65

Np Likeness Score: -1.52

References

1. Che J, Dai X, Gao J, Sheng H, Zhan W, Lu Y, Li D, Gao Z, Jin Z, Chen B, Luo P, Yang B, Hu Y, He Q, Weng Q, Dong X..  (2021)  Discovery of N-((3S,4S)-4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl-1H-pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity.,  64  (16.0): [PMID:34375113] [10.1021/acs.jmedchem.1c00815]

Source

Source(1):

• Scientific Literature